Close Menu

NEW YORK (360Dx) – While Congress appears unlikely to pass federal surprise billing legislation by the end of the year, the issue may become a focus for legislators, both on the federal as well as state level, in 2020.

Although laboratory services have not been at the forefront of the surprise billing discussion, they could see significant impacts from legislation, suggested Erin Duffy, a healthcare policy analyst at the University of Southern California's Leonard D. Schaeffer Center for Health Policy & Economics.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.